Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples